The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment

About this update from Platform Group Se & Co. Kgaa

EQS-News: The Platform Group SE & Co. KGaA / Key word(s): Mergers & Acquisitions/Forecast The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment 26.01.2026 / 18:44 CET/CEST The issuer is solely responsible for the content of this announcement.The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment TPG has been successfully active in the pharmaceutical platform segment since 2021 with ApoNowApoNow is the largest digital interface between local pharmacies and pharmaceutical manufacturers, connecting approx. 41,000 pharmacies across four countriesFollowing the acquisition of AEP, the Pharma segment is expected to reach revenues of EUR 1.1 billionEstablishment of an independent Pharma Group with dedicated managementAdjustment of the 2026 guidance following closingDüsseldorf, 26 January 2026. The Platform Group SE & Co. KGaA (ISIN DE000A40ZW88, WKN A40ZW8, “TPG”), a leading software company for platform solutions, today announced the intended acquisition of AEP GmbH, headquartered in Alzenau, Germany. AEP operates a B2B wholesale platform for the pharmaceutical industry, serving several thousand pharmacies across Germany. The sellers are a group of shareholders, with Österreichische Post AG currently being the majority shareholder. The transaction was signed on 26 January 2026. Closing is expected in the second quarter of 2026, subject to antitrust approval and the fulfillment of customary closing conditions. TPG intends to acquire 100% of the shares in AEP GmbH. AEP is one of the largest pharmaceutical trading companies in Germany, most recently generating revenues of more than EUR 1 billion. The company is profitable and has established itself as a key player in the German pharmaceutical market. AEP currently employs around 250 people, and its central warehouse in Alzenau is among the most modern pharmaceutical logistics centers in Europe. The parties have agreed not to disclose the purchase price.Dr. Dominik Benner, CEO of The Platform Group: “With AEP, we are taking the next step in expanding and strengthening our strategic positioning in the pharmaceutical sector. We have been active in this field since 2021 and are already connected to more than 39,800 pharmacies in ...

View stock analysis, news, and events for Platform Group Se & Co. Kgaa